HHS To Announce Final Plan For Coverage Of Patient Care Costs In All Clinical Trials.
White House Appoints Slamon To Cancer Panel; Brinker To Address Republican Convention.
Henry Brem Named Director Of Neurology At Johns Hopkins.
Cancer Groups Oppose Plan To Cut Drug Reimbursement.
Edward Benz Named President Of Dana-Farber Cancer Institute.
Univ. of Iowa Cancer Center Wins NCI Cancer Center Grant.
75% Of Fed Research Funds Pay Direct Costs, Study Says.
More Women Over 50 Report Having Had Mammograms.
US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma.
FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.
Sweden Approves Photofrin For Palliation Of Two Cancers.
Firm Buys Rights To NKT Cells From Beth Israel Deaconess.
Trending Stories
- The Directors: Tom Lynch and Skip Burris on how NIH funding cuts imperil biopharma innovation—and cost patient lives
In a time of uncertainty, “react to the knowns, not the fear” - As cancer scientists, we must change how we engage with the public on the impact of NIH cuts
What the scientific method obscures - In weekly vigils, current and former NIH staff grieve the impact of Trump cuts
The Saturday gatherings at NIH’s Metro station are part graveside service, part street theater - She flew Black Hawks and battled cancer—now Col. Susan Fondy grapples with cuts to lymphedema research
- Scaling excellence: How City of Hope is transforming cancer care delivery
- First-ever financial toxicity tumor board aims to change the standard of care
Researchers focus on debt as a side effect of cancer, treatment amid cuts to Medicaid, NCI
